Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients

Abstract In addition to an inflammatory reaction, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-infected patients present lymphopenia, which we recently reported as being related to abnormal programmed cell death. As an efficient humoral response requires CD4 T-cell help, we hypothesi...

Full description

Bibliographic Details
Main Authors: Sonia André, Marne Azarias da Silva, Morgane Picard, Aurélie Alleaume-Buteau, Lucy Kundura, Renaud Cezar, Calaiselvy Soudaramourty, Santa Cruz André, Ana Mendes-Frias, Alexandre Carvalho, Carlos Capela, Jorge Pedrosa, António Gil Castro, Paul Loubet, Albert Sotto, Laurent Muller, Jean-Yves Lefrant, Claire Roger, Pierre-Géraud Claret, Sandra Duvnjak, Tu-Anh Tran, Ouafa Zghidi-Abouzid, Pierre Nioche, Ricardo Silvestre, Pierre Corbeau, Fabrizio Mammano, Jérôme Estaquier
Format: Article
Language:English
Published: Nature Publishing Group 2022-08-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-05190-0
_version_ 1811183281283006464
author Sonia André
Marne Azarias da Silva
Morgane Picard
Aurélie Alleaume-Buteau
Lucy Kundura
Renaud Cezar
Calaiselvy Soudaramourty
Santa Cruz André
Ana Mendes-Frias
Alexandre Carvalho
Carlos Capela
Jorge Pedrosa
António Gil Castro
Paul Loubet
Albert Sotto
Laurent Muller
Jean-Yves Lefrant
Claire Roger
Pierre-Géraud Claret
Sandra Duvnjak
Tu-Anh Tran
Ouafa Zghidi-Abouzid
Pierre Nioche
Ricardo Silvestre
Pierre Corbeau
Fabrizio Mammano
Jérôme Estaquier
author_facet Sonia André
Marne Azarias da Silva
Morgane Picard
Aurélie Alleaume-Buteau
Lucy Kundura
Renaud Cezar
Calaiselvy Soudaramourty
Santa Cruz André
Ana Mendes-Frias
Alexandre Carvalho
Carlos Capela
Jorge Pedrosa
António Gil Castro
Paul Loubet
Albert Sotto
Laurent Muller
Jean-Yves Lefrant
Claire Roger
Pierre-Géraud Claret
Sandra Duvnjak
Tu-Anh Tran
Ouafa Zghidi-Abouzid
Pierre Nioche
Ricardo Silvestre
Pierre Corbeau
Fabrizio Mammano
Jérôme Estaquier
author_sort Sonia André
collection DOAJ
description Abstract In addition to an inflammatory reaction, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-infected patients present lymphopenia, which we recently reported as being related to abnormal programmed cell death. As an efficient humoral response requires CD4 T-cell help, we hypothesized that the propensity of CD4 T cells to die may impact the quantity and quality of the humoral response in acutely infected individuals. In addition to specific immunoglobulins (Ig)A, IgM, and IgG against SARS-CoV-2 nucleocapsid (N), membrane (M), and spike (S1) proteins, we assessed the quality of IgG response by measuring the avidity index. Because the S protein represents the main target for neutralization and antibody-dependent cellular cytotoxicity responses, we also analyzed anti-S-specific IgG using S-transfected cells (S-Flow). Our results demonstrated that most COVID-19 patients have a predominant IgA anti-N humoral response during the early phase of infection. This specific humoral response preceded the anti-S1 in time and magnitude. The avidity index of anti-S1 IgG was low in acutely infected individuals compared to convalescent patients. We showed that the percentage of apoptotic CD4 T cells is inversely correlated with the levels of specific IgG antibodies. These lower levels were also correlated positively with plasma levels of CXCL10, a marker of disease severity, and soluble Fas ligand that contributes to T-cell death. Finally, we found lower S-Flow responses in patients with higher CD4 T-cell apoptosis. Altogether, these results demonstrate that individuals with high levels of CD4 T-cell apoptosis and CXCL10 have a poor ability to build an efficient anti-S response. Consequently, preventing CD4 T-cell death might be a strategy for improving humoral response during the acute phase, thereby reducing COVID-19 pathogenicity.
first_indexed 2024-04-11T09:45:26Z
format Article
id doaj.art-6fecc8e6b5164568af51fbebea43c83e
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-04-11T09:45:26Z
publishDate 2022-08-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-6fecc8e6b5164568af51fbebea43c83e2022-12-22T04:31:05ZengNature Publishing GroupCell Death and Disease2041-48892022-08-0113811510.1038/s41419-022-05190-0Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patientsSonia André0Marne Azarias da Silva1Morgane Picard2Aurélie Alleaume-Buteau3Lucy Kundura4Renaud Cezar5Calaiselvy Soudaramourty6Santa Cruz André7Ana Mendes-Frias8Alexandre Carvalho9Carlos Capela10Jorge Pedrosa11António Gil Castro12Paul Loubet13Albert Sotto14Laurent Muller15Jean-Yves Lefrant16Claire Roger17Pierre-Géraud Claret18Sandra Duvnjak19Tu-Anh Tran20Ouafa Zghidi-Abouzid21Pierre Nioche22Ricardo Silvestre23Pierre Corbeau24Fabrizio Mammano25Jérôme Estaquier26Université Paris Cité, INSERM U1124Université Paris Cité, INSERM U1124Université Paris Cité, INSERM U1124Université Paris Cité, INSERM U1124Laboratoire d’Immunologie, CHU de NîmesLaboratoire d’Immunologie, CHU de NîmesUniversité Paris Cité, INSERM U1124Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of MinhoDepartment of Internal Medicine, Hospital of BragaLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of MinhoLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of MinhoLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of MinhoLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of MinhoService des Maladies Infectieuses et Tropicales, CHU de NîmesService des Maladies Infectieuses et Tropicales, CHU de NîmesService de Réanimation Chirugicale, CHU de NîmesService de Réanimation Chirugicale, CHU de NîmesService de Réanimation Chirugicale, CHU de NîmesUrgences Médico-Chirugicales Hospitalisation, CHU de NîmesService de Gérontologie et Prévention du Vieillissement, CHU de NîmesService de Pédiatrie, CHU de NîmesCHU de Québec—Université Laval Research CenterUniversité Paris Cité, INSERM U1124Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of MinhoLaboratoire d’Immunologie, CHU de NîmesUniversité Paris Cité, INSERM U1124Université Paris Cité, INSERM U1124Abstract In addition to an inflammatory reaction, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-infected patients present lymphopenia, which we recently reported as being related to abnormal programmed cell death. As an efficient humoral response requires CD4 T-cell help, we hypothesized that the propensity of CD4 T cells to die may impact the quantity and quality of the humoral response in acutely infected individuals. In addition to specific immunoglobulins (Ig)A, IgM, and IgG against SARS-CoV-2 nucleocapsid (N), membrane (M), and spike (S1) proteins, we assessed the quality of IgG response by measuring the avidity index. Because the S protein represents the main target for neutralization and antibody-dependent cellular cytotoxicity responses, we also analyzed anti-S-specific IgG using S-transfected cells (S-Flow). Our results demonstrated that most COVID-19 patients have a predominant IgA anti-N humoral response during the early phase of infection. This specific humoral response preceded the anti-S1 in time and magnitude. The avidity index of anti-S1 IgG was low in acutely infected individuals compared to convalescent patients. We showed that the percentage of apoptotic CD4 T cells is inversely correlated with the levels of specific IgG antibodies. These lower levels were also correlated positively with plasma levels of CXCL10, a marker of disease severity, and soluble Fas ligand that contributes to T-cell death. Finally, we found lower S-Flow responses in patients with higher CD4 T-cell apoptosis. Altogether, these results demonstrate that individuals with high levels of CD4 T-cell apoptosis and CXCL10 have a poor ability to build an efficient anti-S response. Consequently, preventing CD4 T-cell death might be a strategy for improving humoral response during the acute phase, thereby reducing COVID-19 pathogenicity.https://doi.org/10.1038/s41419-022-05190-0
spellingShingle Sonia André
Marne Azarias da Silva
Morgane Picard
Aurélie Alleaume-Buteau
Lucy Kundura
Renaud Cezar
Calaiselvy Soudaramourty
Santa Cruz André
Ana Mendes-Frias
Alexandre Carvalho
Carlos Capela
Jorge Pedrosa
António Gil Castro
Paul Loubet
Albert Sotto
Laurent Muller
Jean-Yves Lefrant
Claire Roger
Pierre-Géraud Claret
Sandra Duvnjak
Tu-Anh Tran
Ouafa Zghidi-Abouzid
Pierre Nioche
Ricardo Silvestre
Pierre Corbeau
Fabrizio Mammano
Jérôme Estaquier
Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients
Cell Death and Disease
title Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients
title_full Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients
title_fullStr Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients
title_full_unstemmed Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients
title_short Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients
title_sort low quantity and quality of anti spike humoral response is linked to cd4 t cell apoptosis in covid 19 patients
url https://doi.org/10.1038/s41419-022-05190-0
work_keys_str_mv AT soniaandre lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT marneazariasdasilva lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT morganepicard lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT aureliealleaumebuteau lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT lucykundura lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT renaudcezar lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT calaiselvysoudaramourty lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT santacruzandre lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT anamendesfrias lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT alexandrecarvalho lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT carloscapela lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT jorgepedrosa lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT antoniogilcastro lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT paulloubet lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT albertsotto lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT laurentmuller lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT jeanyveslefrant lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT claireroger lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT pierregeraudclaret lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT sandraduvnjak lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT tuanhtran lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT ouafazghidiabouzid lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT pierrenioche lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT ricardosilvestre lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT pierrecorbeau lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT fabriziomammano lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients
AT jeromeestaquier lowquantityandqualityofantispikehumoralresponseislinkedtocd4tcellapoptosisincovid19patients